Cryopraxis Release: Cardiac Cell Therapy Phase III Trial to Treat Refractory Angina
11/6/2012 9:59:02 AM
RIO DE JANEIRO--(BUSINESS WIRE)--CryopraxisTM/CellPraxis® aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013. The phase IIA/B clinical trial study was completed in December 2011. These trials involved the use of a proprietary autologous stem cell formulation (MonocellTM) indicated for neoangiogeneses.